Back to news archive
Image for Funding from the Horizon 2020 SME Instrument
Grants & Awards 2018-03-26

Funding from the Horizon 2020 SME Instrument

Gradientech receives funding in the latest call for the phase 1 of the Horizon SME Instrument program. The SME Instrument phase 1 funding will support our continued market driven development of our diagnostic system for rapid antibiotic susceptibility testing (AST), with focus on exploring the US market and finalizing the clinical validation plans for the intended CE-marking of the system.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book